VERU Veru Inc

P/E --
Forward P/E 117.65
Price/Sales 3.11
Beta -1.196
Div Yield --
Market Cap --

Company Analysis

Latest News

Veru stock surges on Novo Nordisk deal for Wegovy obesity trial

Veru stock surges on Novo Nordisk deal for Wegovy obesity trial

Veru Inc. entered a clinical supply agreement with Novo Nordisk for the Phase 2b PLATEAU trial. Novo Nordisk will provide its weight-loss drug Wegovy...